Author: Tadepalli, Satish; Vanjarapu, Jagan Mohan Rao; De Dona, Anna; Cheriyath, Pramil; Nookala, Vinod
Title: The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series Cord-id: 6cb8afxl Document date: 2020_6_15
ID: 6cb8afxl
Snippet: An outbreak of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) infection started in December 2019 in China that resulted in a global health emergency. The World Health Organization later named the disease as coronavirus disease 2019 (COVID-19). Currently, there is no effective treatment available and the data are evolving through continuous clinical trials and ongoing research. Severe infections present with hypoxemic respiratory failure from acute respiratory distress synd
Document: An outbreak of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) infection started in December 2019 in China that resulted in a global health emergency. The World Health Organization later named the disease as coronavirus disease 2019 (COVID-19). Currently, there is no effective treatment available and the data are evolving through continuous clinical trials and ongoing research. Severe infections present with hypoxemic respiratory failure from acute respiratory distress syndrome as one of the major complications. We report two cases of COVID-19 patients who initially presented with moderate to severe symptoms. Later, their clinical course worsened despite ongoing treatment with multiple medications such as hydroxychloroquine and azithromycin until they were started on tocilizumab. Within a short period after they were administered tocilizumab, their oxygen saturation improved and other inflammatory markers such as D-dimer levels, lactate dehydrogenase, and ferritin levels decreased. There is an increase in the amount of research citing the role of various cytokines in the pathophysiology of COVID-19. Targeting the inflammatory mediators in the pathogenesis, especially interleukin-6 pathway inhibitors, would improve overall morbidity and mortality, thus decreasing the burden on healthcare systems.
Search related documents:
Co phrase search for related documents- absolute lymphocyte count and acute respiratory distress syndrome: 1, 2, 3, 4
- absolute lymphocyte count and liver function: 1, 2
- absolute lymphocyte count and lung injury: 1, 2
- absolute lymphocyte count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- absolute lymphocyte count and lymphocyte lymphopenia: 1, 2, 3, 4, 5, 6, 7, 8
- absolute lymphocyte count lymphocyte and acute kidney injury: 1
- absolute lymphocyte count lymphocyte and acute respiratory distress syndrome: 1
- absolute lymphocyte count lymphocyte and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- absolute neutrophil count and acute kidney injury: 1
- absolute neutrophil count and acute respiratory distress syndrome: 1, 2, 3, 4, 5
- absolute neutrophil count and liver function: 1, 2, 3, 4
- absolute neutrophil count and lung injury: 1
- absolute neutrophil count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
- absolute neutrophil count and lymphocyte lymphopenia: 1, 2
- absolute neutrophil count neutrophil and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- activity relationship and liver function: 1
- activity relationship and lung injury: 1
- acute 11 respiratory distress syndrome and lung injury: 1
- acute 11 respiratory distress syndrome and lymphocyte count: 1
Co phrase search for related documents, hyperlinks ordered by date